Engineering clinically-relevant human fibroblastic cell-derived extracellular matrices

被引:18
|
作者
Franco-Barraza, Janusz [1 ]
Raghavan, Kristopher S. [1 ,2 ]
Luong, Tiffany [1 ]
Cukierman, Edna [1 ]
机构
[1] Fox Chase Canc Ctr, Martin & Concetta Greenberg Pancreat Canc Inst, Canc Biol, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[2] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
来源
CELL-DERIVED MATRICES, PT A | 2020年 / 156卷
关键词
CANCER-ASSOCIATED FIBROBLASTS; TUMOR-ASSOCIATED FIBROBLASTS; STROMAL FIBROBLASTS; GROWTH; MICROENVIRONMENT; PROLIFERATION; STROMAGENESIS; MAINTENANCE; ACTIVATION; MIGRATION;
D O I
10.1016/bs.mcb.2019.11.014
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Three-dimensional (3D) culturing models, replicating in vivo tissue microenvironments that incorporate native extracellular matrix (ECM), have revolutionized the cell biology field. Fibroblastic cells generate lattices of interstitial ECM proteins. Cell interactions with ECMs and with molecules sequestered/stored within these are crucial for tissue development and homeostasis maintenance. Hence, ECMs provide cells with biochemical and biomechanical cues to support and locally control cell function. Further, dynamic changes in ECMs, and in cell-ECM interactions, partake in growth, development, and temporary occurrences such as acute wound healing. Notably, dysregulation in ECMs and fibroblasts could be important triggers and modulators of pathological events such as developmental defects, and diseases associated with fibrosis and chronic inflammation such as cancer. Studying the type of fibroblastic cells producing these matrices and how alterations to these cells enable changes in ECMs are of paramount importance. This chapter provides a step-by-step method for producing multilayered (e.g., 3D) fibroblastic cell-derived matrices (fCDM). Methods also include means to assess ECM topography and other cellular traits, indicative of fibroblastic functional statuses, like naive/normal vs. inflammatory and/or myofibroblastic. For these, protocols include indications for isolating normal and diseased fibroblasts (i.e., cancer-associated fibroblasts known as CAFs). Protocols also include means for conducting microscopy assessments, querying whether fibroblasts present with fCDM-dependent normal or CAF phenotypes. These are supported by discrete semi-quantitative digital imaging analyses, providing some imaging processing advice. Additionally, protocols include descriptions for effective fCDM decellularization, which renders cellular debris-free patho/physiological in vivo-like scaffolds, suitable as 3D substrates for subsequent cell culturing.
引用
收藏
页码:109 / 160
页数:52
相关论文
共 50 条
  • [21] Effect of extracellular matrices on production and potency of mesenchymal stem cell-derived exosomes
    Somadder, Rittika
    Faraj, Lina
    Datta, Saurav
    Kanapathipillai, Mathumai
    Ghosh, Gargi
    BIOTECHNOLOGY JOURNAL, 2024, 19 (02)
  • [22] Cartilage engineering using cell-derived extracellular matrix scaffold in vitro
    Jin, Cheng Zhe
    Choi, Byung Hyune
    Park, So Ra
    Min, Byoung-Hyun
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2010, 92A (04) : 1567 - 1577
  • [23] Human Mesenchymal Stem Cell-Derived Matrices for Enhanced Osteoregeneration
    Zeitouni, Suzanne
    Krause, Ulf
    Clough, Bret H.
    Halderman, Hillary
    Falster, Alexander
    Blalock, Darryl T.
    Chaput, Christopher D.
    Sampson, H. Wayne
    Gregory, Carl A.
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (132)
  • [24] The Complexities of Engineering Human Stem Cell-Derived Therapeutics
    Hay, David C.
    Ross, James A.
    Gallagher, Ronnie
    Bagnaninchi, Pierre
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2010,
  • [25] Mesenchymal stem cell-derived extracellular vesicles for human diseases
    Zhang, Xiaofang
    Che, Xiaofang
    Zhang, Sibo
    Wang, Runze
    Li, Mo
    Jin, Yi
    Wang, Tianlu
    Song, Yingqiu
    EXTRACELLULAR VESICLES AND CIRCULATING NUCLEIC ACIDS, 2024, 5 (01): : 64 - 82
  • [26] Innovative models for cardiotoxicity assessment in human pluripotent stem cell-derived cardiomyocytes that enable clinically relevant treatment regimen
    Schwach, V
    Cofino-Fabres, C.
    Slaats, R. H.
    Arbelaez, J. Rivera
    Ten Den, S. A.
    Ribeiro, M. C.
    Passier, R.
    CARDIOVASCULAR RESEARCH, 2024, 120
  • [27] Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system
    Dash, A.
    Figler, R. A.
    Blackman, B. R.
    Marukian, S.
    Collado, M. S.
    Lawson, M. J.
    Hoang, S. A.
    Mackey, A. J.
    Manka, D.
    Cole, B. K.
    Feaver, R. E.
    Sanyal, A. J.
    Wamhoff, B. R.
    TOXICOLOGY IN VITRO, 2017, 39 : 93 - 103
  • [28] Immediate and Delayed Response of Simulated Human Atrial Myocytes to Clinically-Relevant Hypokalemia
    Clerx, Michael
    Mirams, Gary R.
    Rogers, Albert J.
    Narayan, Sanjiv M.
    Giles, Wayne R.
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [29] Methods in cell biology: Cell-derived matrices
    Lorie, Elizabeth Pavez
    Boukamp, Petra
    CELL-DERIVED MATRICES, PT A, 2020, 156 : 309 - +
  • [30] Towards Biomanufacturing of Cell-Derived Matrices
    Chan, Weng Wan
    Yu, Fang
    Le, Quang Bach
    Chen, Sixun
    Yee, Marcus
    Choudhury, Deepak
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)